NCT04599218 - MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer | Biotech Hunter

Enrollment

1,586

Participants

Timeline

Start Date

August 21, 2020

Primary Completion Date

October 15, 2025

Study Completion Date

January 15, 2026

Conditions

Prostate DiseaseElevated Prostate Specific AntigenFamily History of Prostate CancerPositive Digital Rectal ExamProstate Cancer

Interventions

OTHER

Prostate Biopsy

Standard of care

OTHER

MR US Fusion Guided Prostate Biopsy

Trans-rectal ultrasound (TRUS) guided fusion prostate biopsy (Arm 1) or a Transperineal Ultrasound guided fusion prostate biopsy (Arm 2). All patients will under go a standard ultrasound guided biopsy at the time of their targeted (fusion) biopsy.

DEVICE

MR/TRUS Fusion Guided Prostate Biopsy

TRUS images are overlaid on a previously obtained prostate MRI, combined with an electromagnetic tracking system. The urologist then performs directed prostate biopsies at MR-identified targets in addition to the standard prostate biopsies.

Trial Locations (3)

10022

RECRUITING

The Smith Institute for Urology at Lenox Hill, New York

10065

RECRUITING

Manhattan Eye, Ear, and Throat Hospital (MEETH), New York

11042

RECRUITING

The Smith Institute for Urology, Lake Success